66.61MMarket Cap-9074P/E (TTM)
5.100High4.900Low1.62KVolume5.100Open5.050Pre Close8.05KTurnover0.03%Turnover RatioLossP/E (Static)13.59MShares7.13052wk High-35.00P/B23.28MFloat Cap4.50052wk Low--Dividend TTM4.75MShs Float25.800Historical High--Div YieldTTM3.96%Amplitude0.072Historical Low4.985Avg Price1Lot Size
Champions Oncology Stock Forum
Champions Oncology Reports Quarterly Revenue of $14.0 Million
Champions Oncology (Nasdaq: CSBR) reported its financial results for Q4 and fiscal year 2024.
Q4 revenue increased 7% to $14 million, with an adjusted EBITDA income of $884,000.
However, annual revenue decreased 7% to $50.2 million, with a fiscal year 2024 adjusted EBITDA loss of $3.9 million.
The company faced challenges due to the biotech sector's funding environment and pharmaceutical spending p...
Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development
Champions Oncology (CSBR) announced a strategic collaboration with Medicines Discovery Catapult (MDC) to boost the development of radiopharmaceutical therapeutics. This partnership leverages Champions' patient-derived models and pharmacology solutions with MDC's radiochemistry and multi-modal imaging expertise. The collaboration aims...
No comment yet